Fragile X Syndrome

FDA Fast Tracks Treatment for Fragile X Syndrome

FDA Fast Tracks Treatment for Fragile X Syndrome

By

OV101 has previously been granted Orphan Drug status for Fragile X and Fast Track status for Angelman syndrome.

Sign Up for Free e-newsletters

CME Focus